Unité de Biologie des Interactions Hôte-Parasite, Institut Pasteur and CNRS, Paris, France.
PLoS One. 2007 Sep 19;2(9):e910. doi: 10.1371/journal.pone.0000910.
Infection with Plasmodium falciparum during pregnancy is one of the major causes of malaria related morbidity and mortality in newborn and mothers. The complications of pregnancy-associated malaria result mainly from massive adhesion of Plasmodium falciparum-infected erythrocytes (IE) to chondroitin sulfate A (CSA) present in the placental intervillous blood spaces. Var2CSA, a member of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family is the predominant parasite ligand mediating CSA binding. However, experimental evidence suggests that other host receptors, such as hyaluronic acid (HA) and the neonatal Fc receptor, may also support placental binding. Here we used parasites in which var2csa was genetically disrupted to evaluate the contribution of these receptors to placental sequestration and to identify additional adhesion receptors that may be involved in pregnancy-associated malaria. By comparison to the wild-type parasites, the FCR3delta var2csa mutants could not be selected for HA adhesion, indicating that var2csa is not only essential for IE cytoadhesion to the placental receptor CSA, but also to HA. However, further studies using different pure sources of HA revealed that the previously observed binding results from CSA contamination in the bovine vitreous humor HA preparation. To identify CSA-independent placental interactions, FCR3delta var2csa mutant parasites were selected for adhesion to the human placental trophoblastic BeWo cell line. BeWo selected parasites revealed a multi-phenotypic adhesion population expressing multiple var genes. However, these parasites did not cytoadhere specifically to the syncytiotrophoblast lining of placental cryosections and were not recognized by sera from malaria-exposed women in a parity dependent manner, indicating that the surface molecules present on the surface of the BeWo selected population are not specifically expressed during the course of pregnancy-associated malaria. Taken together, these results demonstrate that the placental malaria associated phenotype can not be restored in FCR3delta var2csa mutant parasites and highlight the key role of var2CSA in pregnancy malaria pathogenesis and for vaccine development.
妊娠期间感染恶性疟原虫是导致新生儿和母亲疟疾发病率和死亡率的主要原因之一。妊娠相关疟疾的并发症主要是由于大量恶性疟原虫感染的红细胞(IE)与胎盘绒毛间隙血液中存在的硫酸软骨素 A(CSA)黏附所致。Var2CSA 是恶性疟原虫红细胞膜蛋白 1(PfEMP1)家族的一员,是介导 CSA 结合的主要寄生虫配体。然而,实验证据表明,其他宿主受体,如透明质酸(HA)和新生儿 Fc 受体,也可能支持胎盘结合。在这里,我们使用基因敲除 var2csa 的寄生虫来评估这些受体对胎盘黏附的贡献,并确定可能参与妊娠相关疟疾的其他黏附受体。与野生型寄生虫相比,FCR3delta var2csa 突变体不能被选择用于 HA 黏附,这表明 var2csa 不仅是 IE 与胎盘受体 CSA 黏附所必需的,也是与 HA 黏附所必需的。然而,进一步使用不同来源的 HA 进行的研究表明,之前观察到的结合结果是由于牛玻璃体中 HA 制剂中 CSA 的污染。为了鉴定 CSA 独立的胎盘相互作用,FCR3delta var2csa 突变体寄生虫被选择用于黏附到人类胎盘滋养层 BeWo 细胞系。BeWo 选择的寄生虫显示出一种多表型黏附群体,表达多种 var 基因。然而,这些寄生虫不会特异性黏附到胎盘冷冻切片的合胞滋养层衬里,也不会被暴露于疟疾的妇女的血清以产次依赖的方式识别,这表明 BeWo 选择的群体表面存在的表面分子在妊娠相关疟疾过程中不是特异性表达的。总之,这些结果表明,FCR3delta var2csa 突变体寄生虫中不能恢复与胎盘疟疾相关的表型,并强调了 var2CSA 在妊娠疟疾发病机制和疫苗开发中的关键作用。